Angelman Syndrome clinical trials at UCSF

1 in progress, 0 open to eligible people

GTX-102 in Pediatric Subjects With AS
Sorry, not currently recruiting here
The primary objective of this study is to evaluate the effect of GTX-102 in cognitive function in participants with Angelman Syndrome (AS).
San Francisco, California and other locations

Last updated: December 18, 2024